LEPU BIO-B's stock price soared 14.84% during the intraday session on Thursday, breaking above its half-year moving average.
The significant surge followed the release of the company's annual report, which showed robust financial performance for 2025. Revenue reached 935 million yuan, marking a substantial 154.19% year-on-year increase. Furthermore, the company reported a profit attributable to owners of 261 million yuan, achieving a notable turnaround from a loss to a profit compared to the previous year.